000 | 01247 a2200349 4500 | ||
---|---|---|---|
005 | 20250516154623.0 | ||
264 | 0 | _c20140207 | |
008 | 201402s 0 0 eng d | ||
022 | _a1873-2518 | ||
024 | 7 |
_a10.1016/j.vaccine.2013.05.051 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWhitney, Cynthia G | |
245 | 0 | 0 |
_aWhat do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program. _h[electronic resource] |
260 |
_bVaccine _cJul 2013 |
||
300 |
_aC6-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdvisory Committees |
650 | 0 | 4 | _aCenters for Disease Control and Prevention, U.S. |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 | _aDecision Making |
650 | 0 | 4 | _aEvidence-Based Practice |
650 | 0 | 4 | _aHealth Policy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunization Programs _xeconomics |
650 | 0 | 4 | _aPneumococcal Vaccines |
650 | 0 | 4 | _aRotavirus Vaccines |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aVaccines, Conjugate |
700 | 1 | _aParashar, Umesh D | |
773 | 0 |
_tVaccine _gvol. 31 Suppl 3 _gp. C6-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2013.05.051 _zAvailable from publisher's website |
999 |
_c22846609 _d22846609 |